Alkermes plc.
ALKS
60 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 2 10:07 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $29.29 | $59.6K | — | View → |
| Mar 2, 2026 | Mar 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $29.72 | $267.5K | — | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $33.93 | $305.4K | 57,740(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Sale | 61,200 | $34.57 | $2.1M | 103,744(D) | View → |
| Feb 2, 2026 | Feb 2 9:05 PM | Cooke Shane | Proposed Sale | 61,200 | $34.57 | $2.1M | — | View → |
| Feb 2, 2026 | Feb 2 9:02 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $33.93 | $305.4K | — | View → |
| Jan 8, 2026 | Jan 9 12:38 AM | Hopkinson Craig C. | Proposed Sale | 5,000 | $30.00 | $150.0K | — | View → |
| Jan 2, 2026 | Jan 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 4,000 | $28.00 | $112.0K | — | View → |
| Dec 3, 2025 | Dec 3 9:32 PM | Hopkinson Craig C. | Proposed Sale | 3,748 | $30.00 | $112.4K | — | View → |
| Dec 1, 2025 | Dec 1 9:45 PM | Hopkinson Craig C. | Proposed Sale | 4,000 | $29.30 | $117.2K | — | View → |
| Nov 3, 2025 | Nov 3 9:35 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $30.38 | $273.4K | — | View → |
| Oct 15, 2025 | Oct 15 8:07 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $31.53 | $283.8K | — | View → |
| Jun 10, 2025 | Jun 10 8:29 PM | Nichols Christian Todd | Proposed Sale | 3,334 | $31.09 | $103.7K | — | View → |
| Jun 9, 2025 | Jun 9 8:08 PM | Nichols Christian Todd | Proposed Sale | 3,333 | $31.95 | $106.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | Hopkinson Craig C. | Proposed Sale | 144,419 | $35.53 | $5.1M | — | View → |
| Feb 12, 2025 | Feb 12 9:19 PM | Hopkinson Craig C. | Proposed Sale | 204,921 | $32.78 | $6.7M | — | View → |
| Jan 30, 2025 | Jan 30 10:12 PM | Hopkinson Craig C. | Proposed Sale | 100,918 | $32.05 | $3.2M | — | View → |
| Dec 9, 2024 | Dec 9 10:27 PM | LAURENCIN CATO T | Proposed Sale | 2,691 | $31.85 | $85.7K | — | View → |
| Dec 9, 2024 | Dec 9 10:24 PM | Hopkinson Craig C. | Proposed Sale | 61,151 | $32.07 | $2.0M | — | View → |
| Dec 5, 2024 | Dec 5 9:12 PM | Hopkinson Craig C. | Proposed Sale | 9,221 | $31.50 | $290.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 9:39 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,322 | — | 16,645(D) | View → |
| Feb 26, 2026 | Feb 27 9:38 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 26, 2026 | Feb 27 9:37 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 23, 2026 | Feb 25 10:49 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,283 | — | 2,284(D) | View → |
| Feb 23, 2026 | Feb 25 10:48 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,407 | — | 6,408(D) | View → |
| Feb 23, 2026 | Feb 25 10:47 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,738 | — | 8,738(D) | View → |
| Feb 23, 2026 | Feb 25 10:46 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 23, 2026 | Feb 25 10:44 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 19, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,991 | — | 8,974(D) | View → |
| Feb 18, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,034 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,045 | — | 18,137(D) | View → |
| Feb 18, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 9,300 | — | 27,903(D) | View → |
| Feb 18, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 26,356(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Option Exercise | 61,200 | $31.64 | 0(D) | View → |
← Previous
Page 3 of 3